Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Content archived on 2024-05-14

Development of a mineral bone substitute injectable by percutaneous approach and the minimally invasive catheterism technique

Objective



Today, the filling of tumoral hollows and fractural lesions with bone substitutes into the femurs, ibias and humeruses metaphysis and epiphysis is performed with traditional surgical methods which present high risks for the patients and generate high costs for the community. The development of a mineral bone substitute injectable by percutaneous approach and the minimally invasive catheterism technique will be a solution to these problems. Research is necessary to develop a new bone substitute which fluidness to allow the injection will not alter its biocompatible, bioresorbable and mechanical strength properties after setting a ardening. Research is also required to develop miniature drilling bit, tools and guides to optimize the catt rajectory and provide the best minimally invasive therapy.

Topic(s)

Data not available

Call for proposal

Data not available

Coordinator

TEKNIMED S.A.
EU contribution
No data
Address
8,Rue du Corps Franc-Pommiès 8
65502 VIC EN BIGORRE
France

See on map

Total cost
No data

Participants (1)